Merck KGaA
Merck KGaA appoints Frederic Wohlwend
February 7, 2011Sales and Marketing Frederic Wohlwend, Merck KGaA, appointment, sales and marketing
Frederic Wohlwend has been promoted to chief information officer at Merck KGaA with effect from 1 April. He succeeds Kai …
Novartis MS drug steals march over Merck rival
January 24, 2011Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis
Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …
Merck Serono and Domain to co-develop Parkinson’s drugs
January 18, 2011Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4
Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …
Merck KGaA opens outsourcing centre in India
January 5, 2011Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing
Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …
Merck KGaA appoints new head of pharma
December 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing
Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
FDA approves Merck’s HIV fat drug Egrifta
November 12, 2010Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin
US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …
Merck will appeal EMA’s Movectro decision
October 12, 2010Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro
Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …
Merck KGaA’s oral MS therapy gains US priority review
July 29, 2010Sales and Marketing Cladribine, MS, Merck KGaA
Merck’s cladribine has been granted a priority review status by the FDA in a move that could see it come …
Merck Millipore unveiled as $7bn acquisition completed
July 20, 2010Manufacturing and Production Merck KGaA, Millipore
Germany’s Merck KGaA has completed its $7 billion acquisition of processing equipment specialist Millipore, officially launching the combined Merck Millipore …
Merck Serono resubmits oral MS therapy to FDA
June 8, 2010Research and Development Cladribine, MS, Merck KGaA
Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …
Merck bounces back
April 28, 2010Sales and Marketing Merck KGaA
Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …
Trial boost for Merck KGaA’s cladribine
April 19, 2010Research and Development Cladribine, MS, Merck KGaA, Merck Serono
New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
Adverse event halts Merck cancer vaccine trial
March 23, 2010Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines
Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
Merck KGaA invests in bioresearch and bioproduction
March 1, 2010Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services
Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …
Merck KGaA posts modest revenue increase
February 24, 20102009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif
German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth. Revenues increased 2.1% to 7.7 …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
